Intuitive Surgical, Inc. (ISRG) Posts Q1 EPS of $1.13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Intuitive Surgical, Inc. (ISRG) Posts Q1 EPS of $1.13
April 23, 2014 3:26 PM EDT
Barrington Research maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $650. Analyst Charley R. Jones noted that guidance reflects deceleration but he is a buyer on weakness.
"ISRG reported weaker-than-expected Q1/14 results and guidance for the remainder... More
April 23, 2014 8:26 AM EDT
Northland Capital Markets analyst Suraj Kalia reiterated an Underperform rating and $275 price target on Intuitive Surgical (NASDAQ: ISRG) calling Q1 'a bust.'
Kalia commented, "Intuitive's Q1-14 call yesterday had some ominous signs of a different story moving forward. Revs @ $465M completely... More
April 23, 2014 7:01 AM EDT
Jefferies analyst Imron Zafar cut estimates and his price target on Intuitive Surgical (NASDAQ: ISRG) from $595 to $465 following weak Q1 results.
Zafar states, "1Q was weak across the board, and while a procedure guidance... More
April 22, 2014 8:31 AM EDT
Intuitive Surgical, Inc. (Nasdaq: ISRG) announced it has received FDA 510(k) clearance for the da Vinci Sp Surgical System, which is designed to expand the Company's single-incision product offering. This initial clearance is specific to urologic surgical procedures that are appropriate for a... More
